Drug Shortage Report for APO-TADALAFIL PAH

Last updated on 2020-03-03 History
Report ID 105356
Drug Identification Number 02421933
Brand name APO-TADALAFIL PAH
Common or Proper name Tadalafil
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) TADALAFIL
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 60 BTL
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-02-03
Estimated end date 2020-05-08
Actual end date
Shortage status Actual shortage
Updated date 2020-03-03
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-03-03 French Compare
v3 2020-03-03 English Compare
v2 2020-02-05 French Compare
v1 2020-02-05 English Compare